ABSTRACT
Metabolic syndrome (MetS) has been and remains a highly controversial topic. There is a close association of (MetS) with a group of symptoms associated with diseases of the heart, blood vessels, arteries, and accelerated aging. To find out and discover whether the distribution of these associations or the totals of (MetS) components differ from one gender to another or from one ethnicity to another, 110 subjects were selected as a sample at the National Institute of Diabetes, Nutrition and Metabolic Diseases (N.C.Paulescu) In Bucharest, 110 subjects in divided between 47 Males, 63 females with an age range of 54 years for age groups 35 - 65 years. The pathological conditions in the present study were divided into 2 groups: G1: Patients who have metabolic syndrome. G2: Patients without metabolic syndrome. This study, therefore, aims to diagnose metabolic syndrome according to the criteria approved by ATP III (MetS), also known as insulin resistance syndrome or Syndrome X, which is defined as (a group of several conditions that together increase a person’s risk of developing diabetes and increased heart disease), a disease that is achieved by the presence of 3 or more than 5 components that are considered as parameters or directories (MetS); such as “High level of obesity; High triglyceride levels; High blood sugar level; Decrease in HDL, or good cholesterol and High blood pressure,” but not in a condition in which the person has blood pressure. To achieve this goal, a sample of 110 subjects was selected. An increase in the number of patients with metabolic syndrome at a rate of prevalence (71.1%) of type II Diabetes Patients is among those 110 diabetes patients. Especially among the large age groups, by approximately 55%, Metabolic syndrome was diagnosed in 81 patients, and an apparent increase in the number of female patients with metabolic syndrome (44 females, 37 men). Results have also shown that the metabolic syndrome criterions evolved intrinsically among type 2 diabetes patients with high blood pressure as the highest incidence (79.01%). In contrast, the low level of the high-density lipoprotein had come as the minimal incidence (38.39%). The finding confirmed in this study the data indicates that (MetS) is expected in the category of patients with type 2 diabetes, with an estimated rate of up to 70%. In general, and for people with diabetes in particular, new lifestyles and new health interventions must be followed regarding type 2 diabetes in Romania and the world at large in order to stop or neutralize the burdens, complications, and risk of heart disease in patients with diabetes.